Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Alectinib
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/05/2020
Ergotamine
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/05/2020
VS-5584
Potential treatment - theoretical effect Experimental Antiviral Nov/05/2020
Setileuton
Potential treatment - theoretical effect Experimental Antiviral Nov/05/2020
Taraxerol
Potential treatment - theoretical effect Natural product Antiviral Nov/05/2020
Withanolide A
Potential treatment - theoretical effect Natural product Antiviral Nov/05/2020
Nb21
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
Nb213
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
Nb203
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
Eculizumab
Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/04/2020
2-(3-(3-Chloro-4-fluorobenzoyl)-7-fluoro-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl)-N-(4-(trifluoromethyl)phenyl)acetamide
Potential treatment - theoretical effect Experimental Antiviral Nov/04/2020
Sb23
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/04/2020
Mitoxantrone
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/04/2020
BNTX
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/04/2020
Ursolic acid
Potential treatment - theoretical effect Natural product Antiviral Nov/04/2020
TMCB
Potential treatment - theoretical effect Experimental Antiviral Nov/03/2020
4E1RCat
Potential treatment - theoretical effect Experimental Antiviral Nov/03/2020
rbIFN-λ
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/03/2020
anti-spike-S1 IgYs
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/03/2020
Bilobetin
Potential treatment - theoretical effect Natural product Antiviral Nov/03/2020